Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-16 | New | $5,000,000 | $5,000,000 | Other | 06b | SEC link |
| 2024-05-02 | New | $364,629 | $364,629 | Other | 06b | SEC link |
| 2024-02-16 | New | $3,600,003 | $3,600,003 | Other | 06b | SEC link |
| 2023-10-04 | New | $1,569,780 | $1,569,780 | Other | 06b | SEC link |
| 2021-12-20 | New | $1,200,000 | $1,200,000 | Equity Only | 06b | SEC link |
| 2021-07-27 | New | $85,000 | Unknown | Equity Only | SEC link | |
| 2020-07-08 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2020-05-13 | New | $2,039,228 | $2,039,228 | Equity Only | 06b | SEC link |
| 2019-11-19 | New | $492,500 | $492,500 | Equity Only | 06b | SEC link |
| 2019-11-13 | New | $180,000 | $180,000 | Other | 06b | SEC link |
| 2018-11-15 | New | $310,000 | $310,000 | Equity Only | 06c | SEC link |
| 2016-09-13 | New | $108,500 | $108,500 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Nicholas Baxter | Director |
| Christopher Bunka | Director |
| Chris Bunka | Director, Executive |
| Nelson Cabatuan | Executive |
| Richard Christopher | Executive |
| John Docherty | Director, Executive |
| Gregory Downey | Executive |
| Ted Mc Kechnie | Director |
| Ted Mckechnie | Director |
| Brian Quigley | Director |
| Albert Reese | Director |
| Michael Shankman | Executive |
| Allan Spissinger | Executive |
| Catherine Turkel | Director |